Candida spp. in oral cancer and oral precancerous lesions

New Microbiologica

Volumn 36, Issue 3, 2013, Pages 283-288

  Gallè, Francesca ^a   Colella, Giuseppe ^b   Di Onofrio, Valeria ^a   Rossiello, Raffaele ^b   Angelillo, Italo Francesco ^b   Liguori, Giorgio ^a  

^a UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Candida spp.; Microbiological and histological diagnosis; Oral precancer and cancer

Indexed keywords

ADULT; AGED; ARTICLE; BIOPSY; CANDIDA; CANDIDA ALBICANS; COMPARATIVE STUDY; FEMALE; HUMAN; ISOLATION AND PURIFICATION; ITALY; MALE; MICROBIOLOGY; MIDDLE AGED; MOUTH; MOUTH TUMOR; PRECANCER; RISK FACTOR; THRUSH; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, ORAL; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MOUTH; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; RISK FACTORS; YOUNG ADULT;

EID: 84883147019     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. AL-RAWI N.H., TALABANI N.G. (2008). Squamous cell carcinoma of the oral cavity: a case series analysis of clinical presentation and histological grading of 1,425 cases from Iraq. Clin. Oral. Investig. 12, 15-18.
2. BARRETT A.W., KINGSMILL V.J., SPEIGHT P.M. (1998). The frequency of fungal infection in biopsies of oral mucosal lesion. Oral Diseases. 4, 26-31.
3. BASTIAAN R.J., READE P.C. (1982). The prevalence of Candida albicans in the mouths of tobacco smokers with and without oral mucous membrane keratoses. Oral. Surg. Oral Med. Oral Pathol. 53, 148-151.
4. BELAZI M., VELEGRAKI A., KOUSSIDOU-EREMONDI T., ET AL. (2004). Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment. Oral Microbiol. Immunol. 19, 347-351.
5. BRAND A. (2012). Hyphal growth in human fungal pathogens and its role in virulence. Int. J. Microbiol. 517-529.
6. CAWSON R.A. (1969). Leukoplakia and oral cancer. Proc. R. Soc. Med. 62, 610-614.
7. CHEN A.Y., MYERS J.N. (2001). Cancer of the oral cavity. Dis. Mon. 47, 275-361.
8. DAFTARY D.K., MEHTA F.S., GUPTA P.C., PINDBORG J.J. (1972). The presence of Candida in 723 oral leukoplakias among Indian villagers. Scand. J. Dent. Res. 80, 75-79.
9. DE ARAÚJO NAVAS E.A., INOCÊNCIO A.C., ALMEIDA J.D., ET AL. (2009). Oral distribution of Candida species and presence of oral lesions in Brazilian leprosy patients under multidrug therapy. J. Oral. Pathol. Med. 38, 764-767.
10. DWIVEDI P.P., MALLYA S., DONGARI-BAGTZOGLOU A. (2009). A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia. Med. Mycol. 47, 157-167.
11. FARAH C.S., LYNCH N., MCCULLOUGH M.J. (2010). Oral fungal infections: an update for the general practitioner. Aust. Dent. J. 55 (Suppl. 1), 48-54.
12. GONSALVES W.C., WRIGHTSON A.S., HENRY R.G. (2008). Common oral conditions in older persons. Am. Fam. Physician. 78, 845-852.
13. HENRY S., D'HONDT L., ANDRÉ M., HOLEMANS X., CANON J.L. (2004). Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature. Acta Clin. Belg. 59, 220-222.
14. HOOPER S.J., CREAN S.J., FARDY M.J., ET AL. (2007). A molecular analysis of the bacteria present within oral squamous cell carcinoma. J. Med. Microbiol. 56 (Pt 12), 1651-1659.
15. LANDIS J.R., KOCH G.G. (1977). The measurement of observer agreement for categorical data. Biometrics. 33, 159-174.
16. LIGUORI G., DI ONOFRIO V., LUCARIELLO A., ET AL. (2009). Oral candidiasis: a comparison between conventional methods and multiplex polymerase chain reaction for species identification. Oral. Microbiol. Immunol. 24, 76-78.
17. LIGUORI G., LUCARIELLO A., COLELLA G., DE LUCA A., MARINELLI P. (2007). Rapid identification of Candida species in oral rinse solutions by PCR. J. Clin. Pathol. 60, 1035-1039.
18. MANINDER J., USHA A. (2008). Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients. J. Commun. Dis. 40, 177-181.
19. MASHBERG A., MERLETTI F., BOFFETTA P., GANDOLFO S., OZZELLO F., FRACCHIA F., TERRACINI B. (1989). Appearance, site of occurrence, and physical and clinical characteristics of oral carcinoma in Torino, Italy. Cancer. 63, 2522-2527.
20. MCCULLOUGH M., JABER M., BARRETT A.W., BAIN L., SPEIGHT P.M., PORTER S.R. (2002). Oral yeast carriage correlates with presence of oral epithelial dysplasia. Oral. Oncol. 38, 391-393.
21. MORACE G., BORGHI E. (2010). Fungal infections in ICU patients: epidemiology and the role of diagnostics. Minerva Anestesiol. 76, 950-956.
22. NEVILLE B.W., DAY T.A. (2002). Oral cancer and precancerous lesions. CA Cancer J. Clin. 52, 195-215.
23. NIEMINEN M.T., UITTAMO J., SALASPURO M., RAUTEMAA R. (2009). Acetaldehyde production from ethanol and glucose by non-Candida albicans yeasts in vitro. Oral Oncol. 45, 245-248.
24. RAUTEMAA R., HIETANEN J., NIISSALO S., PIRINEN S., PERHEENTUPA J. (2007). Oral and oesophageal squamous cell carcinoma - a complication or component of autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy (APECED, APS-I). Oral. Oncol. 43, 607-613.
25. REIBEL J. (2003). Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit. Rev. Oral. Biol. Med. 14, 47-62.
26. REICHART P.A. (2001). Identification of risk groups for oral precancer and cancer and preventive measures. Clin. Oral. Investig. 5, 207-213.
27. RINDUM J.L., STENDERUP A., HOLMSTRUP P. (1994). Identification of Candida albicans types related to healthy and pathological oral mucosa. J. Oral. Pathol. Med. 23, 406-412.
28. ROBLYER D., KURACHI C., STEPANEK V., WILLIAMS M.D., EL-NAGGAR A.K., LEE J.J., GILLENWATER A.M., RICHARDS-KORTUM R. (2009). Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer. Prev. Res. 2, 423-431.
29. RODRÍGUEZ M.J., SCHNEIDER J., MORAGUES M.D., MARTÍNEZ-CONDE R., PONTÓN J., AGUIRRE J.M. (2007). Cross-reactivity between Candida albicans and oral squamous cell carcinoma revealed by monoclonal antibody C7. Anticancer. Res. 27, 3639-3643.
30. ROSENQUIST K., WENNERBERG J., SCHILDT E.B., BLADSTRÖM A., GÖRAN HANSSON B., ANDERSSON G. (2005). Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A populationbased case-control study in southern Sweden. Acta Otolaryngol. 125, 1327-1336.
31. ROSSANO F., GOMBOS F., LIGUORI G., ET AL. (1993). Malignant transformation of oral Lichen planus by Candida albicans. Int. J. Immunopathol. Pharmacol. 6 (2), 125-134.
32. SALASPURO M. (2007). Interrelationship between alcohol, smoking, acetaldehyde and cancer. Novartis Found Symp. 285, 80-89.
33. SCARDINA G.A., RUGGIERI A., MESSINA P. (2009). Chronic hyperplastic candidosis: a pilot study of the efficacy of 0.18% isotretinoin. J. Oral. Sci. 51, 407-410.
34. SITHEEQUE M.A., SAMARANAYAKE L.P. (2003). Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit. Rev. Oral. Biol. Med. 14, 253-267.
35. WARNAKULASURIYA S., JOHNSON N.W., VAN DER WAAL I. (2007). Nomenclature and classification of potentially malignant disorders of the oral mucosa. J. Oral. Pathol. Med. 36, 575-580.
36. WILLIAMS D.W., BARTIE K.L., POTTS A.J., WILSON M.J., FARDYM.J., LEWISM.A. (2001). Strain persistence of invasive Candida albicans in chronic hyperplastic candidosis that underwent malignant change. Gerodontology. 18, 73-78.
37. WILLIAMSON D.M. (1969). Chronic hyperplastic candidiasis and squamous carcinoma. Br. J. Dermatol. 8, 125-127.
38. WORLD HEALTH ORGANIZATION. (2005). Classification of Tumours. In: Barnes L., Eveson J.W., Reichart P., Sidransky D., eds. Pathology & Genetics. Head and Neck Tumours. Lyon: International Agency for Research on Cancer (IARC) IARC Press.
39. WU L., FENG J., SHI L., SHEN X., LIU W., ZHOU Z. (2012). Candidal infection in oral leukoplakia: a clinicopathologic study of 396 patients from eastern China. Ann. Diagn. Pathol. (in press).